Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

581. Training nursing home staff to improve psychosocial care reduces neuroleptic use in people with dementia without an increase in agitation

Training nursing home staff to improve psychosocial care reduces neuroleptic use in people with dementia without an increase in agitation Training nursing home staff to improve psychosocial care reduces neuroleptic use in people with dementia without an increase in agitation | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies (...) , please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Training nursing home staff to improve psychosocial care reduces neuroleptic use in people with dementia without

2006 Evidence-Based Mental Health

582. Educational workshops and decision support software increase detection of dementia in the elderly in primary care settings

Educational workshops and decision support software increase detection of dementia in the elderly in primary care settings Educational workshops and decision support software increase detection of dementia in the elderly in primary care settings | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Educational workshops and decision support software increase detection of dementia in the elderly in primary care settings Article Text

2006 Evidence-Based Mental Health

583. Global prevalence of dementia: a Delphi consensus study. Full Text available with Trip Pro

Global prevalence of dementia: a Delphi consensus study. 100 years after the first description, Alzheimer's disease is one of the most disabling and burdensome health conditions worldwide. We used the Delphi consensus method to determine dementia prevalence for each world region.12 international experts were provided with a systematic review of published studies on dementia and were asked to provide prevalence estimates for every WHO world region, for men and women combined, in 5-year age bands (...) from 60 to 84 years, and for those aged 85 years and older. UN population estimates and projections were used to estimate numbers of people with dementia in 2001, 2020, and 2040. We estimated incidence rates from prevalence, remission, and mortality.Evidence from well-planned, representative epidemiological surveys is scarce in many regions. We estimate that 24.3 million people have dementia today, with 4.6 million new cases of dementia every year (one new case every 7 seconds). The number

2005 Lancet

584. Withdrawing neuroleptic treatment from people with dementia, does not result in a significant change to their behaviour, psychiatric symptoms, or quality of life Full Text available with Trip Pro

Withdrawing neuroleptic treatment from people with dementia, does not result in a significant change to their behaviour, psychiatric symptoms, or quality of life Withdrawing neuroleptic treatment from people with dementia, does not result in a significant change to their behaviour, psychiatric symptoms, or quality of life | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser (...) at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Withdrawing neuroleptic treatment from people with dementia

2005 Evidence-Based Mental Health

585. Rofecoxib did not slow progression of dementia in patients with established Alzheimer’s disease Full Text available with Trip Pro

Rofecoxib did not slow progression of dementia in patients with established Alzheimer’s disease Rofecoxib did not slow progression of dementia in patients with established Alzheimer’s disease | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Rofecoxib did not slow progression of dementia in patients with established Alzheimer’s disease Article Text Therapeutics Rofecoxib did not slow progression of dementia in patients with established

2005 Evidence-Based Medicine

586. DemTect effective in screening for mild cognitive impairment and mild dementia Full Text available with Trip Pro

DemTect effective in screening for mild cognitive impairment and mild dementia DemTect effective in screening for mild cognitive impairment and mild dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here DemTect effective in screening for mild cognitive impairment and mild dementia Article Text Diagnosis DemTect effective in screening for mild cognitive impairment and mild dementia Free Angela K Troyer , PhD, CPsych Statistics from

2005 Evidence-Based Mental Health

587. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. Full Text available with Trip Pro

Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. To evaluate any association between obesity in middle age, measured by body mass index and skinfold thickness, and risk of dementia later in life.Analysis of prospective data from a multiethnic population based cohort.Kaiser Permanente Northern California Medical Group, a healthcare delivery organisation.10,276 men and women who underwent detailed health evaluations from 1964 to 1973 when they were (...) aged 40-45 and who were still members of the health plan in 1994.Diagnosis of dementia from January 1994 to April 2003. Time to diagnosis was analysed with Cox proportional hazard models adjusted for age, sex, race, education, smoking, alcohol use, marital status, diabetes, hypertension, hyperlipidaemia, stroke, and ischaemic heart disease.Dementia was diagnosed in 713 (6.9%) participants. Obese people (body mass index > or = 30) had a 74% increased risk of dementia (hazard ratio 1.74, 95

2005 BMJ

588. Multisensory stimulation was not better than usual activities for changing cognition, behaviour, and mood in dementia Full Text available with Trip Pro

Multisensory stimulation was not better than usual activities for changing cognition, behaviour, and mood in dementia Multisensory stimulation was not better than usual activities for changing cognition, behaviour, and mood in dementia | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Multisensory stimulation was not better than usual activities for changing cognition, behaviour, and mood in dementia Article Text Treatment Multisensory stimulation

2005 Evidence-Based Nursing

589. Cognitive stimulation therapy improved cognition and quality of life in dementia Full Text available with Trip Pro

Cognitive stimulation therapy improved cognition and quality of life in dementia Cognitive stimulation therapy improved cognition and quality of life in dementia | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Cognitive stimulation therapy improved cognition and quality of life in dementia Article Text Treatment Cognitive stimulation therapy improved cognition and quality of life in dementia Free Dorothy Forbes , RN, PhD Statistics from

2005 Evidence-Based Nursing

590. Dementia may affect 18 319 people under the age of 65 in the UK Full Text available with Trip Pro

Dementia may affect 18 319 people under the age of 65 in the UK Dementia may affect 18 319 people under the age of 65 in the UK | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your (...) user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Dementia may affect 18 319 people under the age of 65 in the UK Article Text Prevalence Dementia may affect 18 319 people under the age of 65 in the UK Free Joyce C Pressley , PhD MPH Statistics from Altmetric.com Harvey RJ, Skelton-Robinson M, Rossor MN

2005 Evidence-Based Mental Health

591. The Prueba Cognitiva de Leganés is a valid screening tool for diagnosing dementia in people with low educational level Full Text available with Trip Pro

The Prueba Cognitiva de Leganés is a valid screening tool for diagnosing dementia in people with low educational level The Prueba Cognitiva de Leganés is a valid screening tool for diagnosing dementia in people with low educational level | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here The Prueba Cognitiva de Leganés is a valid screening tool for diagnosing dementia in people with low educational level Article Text Diagnosis The Prueba

2005 Evidence-Based Mental Health

592. The Mini-Cog compares well with longer screening tests for detecting dementia in older people Full Text available with Trip Pro

The Mini-Cog compares well with longer screening tests for detecting dementia in older people The Mini-Cog compares well with longer screening tests for detecting dementia in older people | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here The Mini-Cog compares well with longer screening tests for detecting dementia in older people Article Text Diagnosis The Mini-Cog compares well with longer screening tests for detecting dementia

2005 Evidence-Based Mental Health

593. Cognitive stimulation therapy improved cognition and quality of life in dementia Full Text available with Trip Pro

Cognitive stimulation therapy improved cognition and quality of life in dementia Cognitive stimulation therapy improved cognition and quality of life in dementia | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional (...) accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Cognitive stimulation therapy improved cognition and quality of life in dementia Article Text Therapeutics Cognitive stimulation therapy improved cognition and quality of life in dementia Free Calvin H Hirsch , MD Statistics

2005 Evidence-Based Medicine

594. Cognitive stimulation therapy improves cognition and quality of life in older people with dementia Full Text available with Trip Pro

Cognitive stimulation therapy improves cognition and quality of life in older people with dementia Cognitive stimulation therapy improves cognition and quality of life in older people with dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Cognitive stimulation therapy improves cognition and quality of life in older people with dementia Article Text Therapeutics Cognitive stimulation therapy improves cognition and quality

2005 Evidence-Based Mental Health

595. Dementia.

Dementia. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines and Measures Funding for the National Guideline Clearinghouse (NGC) has ended. Learn more about

2005 American Medical Directors Association

596. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology

Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology Smith S C, Lamping D L, Banerjee S (...) , Harwood R, Foley B, Smith P, et al Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Smith S C, Lamping D L, Banerjee S, Harwood R, Foley B, Smith P, et al. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technology Assessment 2005; 9

2005 Health Technology Assessment (HTA) Database.

597. Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases

Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases MacLean CH, Issa AM, Newberry SJ, Mojica WA, Morton SC, Garland RH, Hilton LG, Traina SB, Shekelle PG Record Status This is a bibliographic record of a published health technology assessment from (...) a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation MacLean CH, Issa AM, Newberry SJ, Mojica WA, Morton SC, Garland RH, Hilton LG, Traina SB, Shekelle PG. Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 114. 2005 Authors' objectives The aim of this study was to assess the effect of omega

2005 Health Technology Assessment (HTA) Database.

598. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence Full Text available with Trip Pro

Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence Sink K M, Holden K F, Yaffe K CRD summary This review concluded that of the drugs used for treating neuropsychiatric symptoms of dementia, risperidone and olanzapine had the best evidence for efficacy although (...) their effect sizes were modest and they increased the risk of stroke. This conclusion appears reasonable. However, there was only a small evidence base for most of the drugs considered in the review. Authors' objectives To evaluate the efficacy of pharmacological agents used in the treatment of neuropsychiatric symptoms of dementia. Searching MEDLINE (from 1966 to July 2004) and the Cochrane Database of Systematic Reviews were searched for English language articles; the search terms were reported

2005 DARE.

599. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 DARE.

600. Use of preferred music to decrease agitated behaviours in older people with dementia: a review of the literature Full Text available with Trip Pro

Use of preferred music to decrease agitated behaviours in older people with dementia: a review of the literature Use of preferred music to decrease agitated behaviours in older people with dementia: a review of the literature Use of preferred music to decrease agitated behaviours in older people with dementia: a review of the literature Sung H C, Chang A M CRD summary This review found that preferred music had positive effects on decreasing agitated behaviours in older adults with dementia (...) ; however, methodological limitations indicate a need for further research. The evidence presented was insufficient to provide robust evidence and the call for further research would appear appropriate. Furthermore, the review itself was limited in terms of reporting methodology and publication bias. Authors' objectives To review the effects of preferred music on agitated behaviours for older people with dementia. Searching MEDLINE, CINAHL, PsycINFO, PsycARTICLES and the Cochrane Database of Systematic

2005 DARE.